Increased Application of Novel Regenerative Therapeutics Achieved Through Integrated CGMP Process Development Optimization

The Mayo Clinic CRM Biotrust has the role of escalating promising cellular and acellular biologics from bench to clinical-grade products, through stringent quality and manufacturing practice documentation and validation. With the purchase of a clinical-grade cell sorter, the CRM Biotrust will further the integration and optimization of process development and CGMP manufacturing platforms and provide increased access to regenerative therapies.